Neurocrine Biosciences (NBIX) EV US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV, bln rub | ? | 7 786 | -726 | -603 | 13 084 | 13 047 | 14 998 | ||
| Changes by years, y/y, % | -9% | -109% | -17% | -2 269% | 0% | +8.9% | |||
Neurocrine Biosciences. EV, bln rub
Neurocrine Biosciences. EV, changes, %
Neurocrine Biosciences (NBIX) EV US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV, bln rub | ? | 10 531 | 11 907 | 13 747 | 13 047 | 12 330 | 14 998 | |
| Changes by years, y/y, % | -1 607% | -1 621% | +29% | +0% | +17% | |||
| Changes by quarters, q/q, % | -19% | +13% | +15% | -5% | -5% | |||